Periphagen is a biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector. Our primary focus is the use of HSV-1 vectors for neurologic disease but we also have extensive experience and HSV-1 vector technology available for other indications. We believe that the best way to treat nervous system diseases is to directly target neurons. We have been developing HSV-1 vecto...
Periphagen is a biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector. Our primary focus is the use of HSV-1 vectors for neurologic disease but we also have extensive experience and HSV-1 vector technology available for other indications. We believe that the best way to treat nervous system diseases is to directly target neurons. We have been developing HSV-1 vectors for more than 25 years and have developed a replication defective HSV-1 vector platform called “Neuronal Therapeutics” (NET) for delivery of tissue specific gene expression in sensory neurons .
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.